A Phase II study of M605106 for axillary osmidrosis
Phase 2
- Conditions
- axillary osmidrosis
- Registration Number
- JPRN-jRCT2031200184
- Lead Sponsor
- Infomation Trials Clinical
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
axillary osmidrosis patients
Exclusion Criteria
(1)Not suitable for application of investigational drug from the viewpoint of safety, such as a wound on the axilla, or patients with complications or abnormal findings on the axilla affecting safety assessment.
(2)Patients judged by the investigator or sub-investigator to have a degree of odor(other than axillary odor) that may affect the evaluation of axillary odor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method